Inho Hwang
Daejeon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Behavioral effects of chronic PFHxA exposure on spatial memory function.
Journal: Toxicology
Published: May 13, 2026
Monoterpenoid fluorophthalimide IMiDs that lack human cereblon binding: synthesis and anti-proliferative, anti-angiogenic and anti-inflammatory activities.
Journal: Biochemical and biophysical research communications
Published: May 13, 2025
Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegeneration.
Journal: Journal of biomedical science
Published: April 14, 2025
Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injury.
Journal: Journal of biomedical science
Published: January 11, 2023
3,6'- and 1,6'-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt Inflammation.
Journal: Pharmaceutics
Published: March 03, 2022
Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: July 01, 2021
N-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge.
Journal: ACS pharmacology & translational science
Published: January 29, 2021
Effects of Sunphenon and Polyphenon 60 on proteolytic pathways, inflammatory cytokines and myogenic markers in H2O2-treated C2C12 cells.
Journal: Journal of biosciences
Published: March 06, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026